Experiments have found that BBR can reduce the expression of CD3 + , CD4 + , CD8 + , and Th17 + in lymphocytes, as well as the expression of IL-6, IL-8, and IL-17 inflammatory factors, playing an anti-inflammatory role in the treatment of periodontitis. The gene discussed is CD4; the disease is periodontitis.